Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV:
LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech
company that leverages advancements in science and technology to
build breakthrough ventures that transform human wellness, is
pleased to announce the launch of its new immune support product,
Protect, by its U.S. biosciences subsidiary Mikra
Cellular Sciences Inc. ("Mikra"), with a new bundle sales promotion
where the next 500 customer orders will receive a trial bottle of
Protect at no cost. This bundle sale is available
now at https://bit.ly/mikra-protect.
"With our renewed rigor and focus on the power
of combining the highest quality science-driven clinical research
with a holistic, whole-person approach to natural wellness, the
team at Mikra is delighted to bring a second new product to market
this year," said Meni Morim, CEO of Lifeist. "Through bundled sales
and other promotions, the Mikra team is working hard to further
boost sales and establish a presence in the market. Mikra's next
new science-based product is anticipated to complete R&D and
formulation in Q1, and we look forward to sharing much more about
it at that time."
Protect comes in a tasty gummy
format that combines the antioxidant power of Aronia berries with
the reliable immune support functions of supplemental zinc and
vitamin C, complemented by vitamin D to tackle the shorter days in
winter.
A comprehensive U.S. clinical review underscored
the benefits of Protect's main active
ingredient:
As documented in
previous studies, Aronia berries show potent inhibitory activity
toward various types of infections, which have been attributed to
their potent antioxidant components1.
Regarding other key active ingredients in
Protect, a Swiss clinical review concluded:
These trials document
that adequate intakes of vitamin C and zinc ameliorate symptoms and
shorten the duration of respiratory tract infections including the
common cold2.
Mikra is pushing biosciences beyond the expected
with the belief that it is possible to add more active, vigorous,
enjoyable, and valuable years to your life through protecting and
maintaining your cellular health. Its recent addition of two
innovative natural products aligns with Mikra's commitment to
reaching a wider audience and making their innovative products
readily available to enhance wellness journeys.
Lifeist is committed to bringing natural
products -- backed by real science -- to current and future
customers and looks forward to introducing additional new products
in the first two quarters of 2024.
About Lifeist Wellness Inc.
Sitting at the forefront of the post-pandemic
wellness revolution, Lifeist leverages advancements in science and
technology to build breakthrough companies that transform human
wellness. Portfolio business units include: CannMart, which
operates a B2B wholesale distribution business facilitating
recreational cannabis sales to Canadian provincial government
control boards including for CannMart Labs, a BHO extraction
facility producing high margin cannabis 2.0 products; Australian
Vapes, one of Australia’s largest online retailers of vaporizers
and accessories; and Mikra, a biosciences and consumer wellness
company developing and selling innovative therapies for cellular
health.
Information on Lifeist and its businesses can be
accessed through the links below: www.lifeist.com
https://cannmart.com https://wearemikra.com/
www.australianvaporizers.com.au
Contact: Meni MorimCEOLifeist
Wellness Inc.Ph: 647-362-0390 Email: ir@lifeist.com
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release or has in any way approved
or disapproved of the contents of this press release.
Forward Looking Information
This news release contains “forward-looking
information” within the meaning of applicable securities laws. All
statements contained herein that are not historical in nature
contain forward-looking information. Forward-looking information
can be identified by words or phrases such as “may”, “expect”,
“likely”, “should”, “would”, “plan”, “anticipate”, “intend”,
“potential”, “proposed”, “estimate”, “believe” or the negative of
these terms, or other similar words, expressions and grammatical
variations thereof, or statements that certain events or conditions
“may” or “will” happen.
The forward-looking information contained
herein, including, without limitation, statements related to
Mikra’s new mental health product and expectations relating to
Mikra’s future introduction of new products, are made as of the
date of this news release and are based on assumptions management
believed to be reasonable at the time such statements were made,
including without limitation, expectations that the development of
Mikra’s new immune support product is successfully completed as
anticipated, its expectation that the nutraceutical market will
develop as currently anticipated, the nutraceutical market will
continue to be a multi-billion dollar high-margin market, the
introduction of new products and brands will generate additional
revenue, expectations that CELLF, RESCUE, SERENITY, PROTECT and
other new cellular health products to be developed by Mikra will
gain market acceptance along with the expansion of the market for
nutraceutical products, as well as other considerations that are
believed to be appropriate in the circumstances. While we consider
these assumptions to be reasonable based on information currently
available to management, there is no assurance that such
expectations will prove to be correct. By its nature,
forward-looking information is subject to inherent risks and
uncertainties that may be general or specific and which give rise
to the possibility that expectations, forecasts, predictions,
projections or conclusions will not prove to be accurate, that
assumptions may not be correct, and that objectives, strategic
goals and priorities will not be achieved. A variety of factors,
including known and unknown risks, many of which are beyond our
control, could cause actual results to differ materially from the
forward-looking information in this news release. Such factors
include, without limitation: the failure to successfully develop
Mikra’s new mental health product as anticipated and in a timely
manner, the inability of the Company to develop Mikra’s business as
anticipated, unanticipated changes to current regulations that
would adversely impact Mikra’s business, unforeseen developments
that would delay Mikra’s ability to sell newly developed
nutraceutical products, the risk that the expected demand for
nutraceutical products in general and those of Mikra in particular
does not develop as anticipated and risks relating to the Company’s
ability to execute its business strategy and the benefits
realizable therefrom. Additional risk factors can also be found in
the Company’s current MD&A filed under the Company’s SEDAR
profile at www.sedar.com. Readers are cautioned not to put undue
reliance on forward-looking information. The Company undertakes no
obligation to update or revise any forward-looking information,
whether as a result of new information, future events or otherwise,
except as required by applicable law. Forward-looking statements
contained in this news release are expressly qualified by this
cautionary statement.
Source: Lifeist Wellness Inc.
________________________
1 Potential Benefits of Aronia Melanocarpa Fruits and Their
Constituents in Improving Human Health -
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696386/
2 Immune-enhancing role of vitamin C and zinc and effect on
clinical conditions - https://pubmed.ncbi.nlm.nih.gov/16373990/
Lifeist Wellness (TSXV:LFST)
過去 株価チャート
から 4 2024 まで 5 2024
Lifeist Wellness (TSXV:LFST)
過去 株価チャート
から 5 2023 まで 5 2024